Jiangsu Weiqida Pharmaceutical Co., Ltd., Nantong, China – FDA Inspections

Inspection records and compliance data for Jiangsu Weiqida Pharmaceutical Co., Ltd. in Nantong. 3 FDA inspections on record, 2 Form 483s, last inspected March 21, 2025.

Company Profile

This profile covers Jiangsu Weiqida Pharmaceutical Co., Ltd. based in Nantong, China.

FDA Inspection History

FDA inspections: 3
OAI: 0
VAI: 2
NAI: 0
Unclassified: 1
Form 483s: 2
Warning letters: 0

First inspected April 30, 2014. Last inspected March 21, 2025.

FDA inspections (3)

Date	Result	FDA center(s)	Insp. #
March 21, 2025	Not classified	Human Drugs	1265662
December 15, 2017	VAI	Human Drugs · Drug Quality Assurance	1038055
April 30, 2014	VAI	Human Drugs · Drug Quality Assurance	880208

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Other regulators (1)

China NMPA · 4 inspections · last October 15, 2015

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Shanghai Desano Chemical Pharmaceutical Co., Ltd.

Qinhuangdao Zizhu Pharmaceutical Co., Ltd.

Shenzhou Jiheng Pharmaceutical Co., Ltd.

Maanshan Cosmos Chemical Co., Ltd.

Zhejiang Chempacific Corporation

Hefei Lifeon Pharmaceutical Co., Ltd. (API branch)

Zhejiang Liaoyuan Pharmaceutical Co., Ltd.

Wuzhou Huangpu Chemical Pharmaceutical Co., Ltd.

Zhejiang Hengkang Pharmaceutical Co., Ltd

Yantai Dongcheng Biochemicals Co., Ltd.